View ValuationCamex 将来の成長Future 基準チェック /06現在、 Camexの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長19.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 10.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (25% accrual ratio). Market cap is less than US$10m (₹433.7m market cap, or US$4.53m). Minor Risk Share price has been volatile over the past 3 months (10.0% average weekly change).Reported Earnings • May 14Full year 2026 earnings released: EPS: ₹3.21 (vs ₹1.86 in FY 2025)Full year 2026 results: EPS: ₹3.21 (up from ₹1.86 in FY 2025). Revenue: ₹1.50b (up 12% from FY 2025). Net income: ₹32.5m (up 72% from FY 2025). Profit margin: 2.2% (up from 1.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 21% per year.Valuation Update With 7 Day Price Move • May 13Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹35.40, the stock trades at a trailing P/E ratio of 22.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 42% over the past three years.お知らせ • May 07Camex Limited to Report Q4, 2026 Results on May 12, 2026Camex Limited announced that they will report Q4, 2026 results on May 12, 2026Reported Earnings • Feb 06Third quarter 2026 earnings released: EPS: ₹0.80 (vs ₹0.31 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹0.80 (up from ₹0.31 loss in 3Q 2025). Revenue: ₹366.9m (up 30% from 3Q 2025). Net income: ₹8.18m (up ₹11.4m from 3Q 2025). Profit margin: 2.2% (up from net loss in 3Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 02Camex Limited to Report Q3, 2026 Results on Feb 05, 2026Camex Limited announced that they will report Q3, 2026 results on Feb 05, 2026Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹0.27 loss per share (vs ₹1.43 profit in 2Q 2025)Second quarter 2026 results: ₹0.27 loss per share (down from ₹1.43 profit in 2Q 2025). Revenue: ₹373.0m (up 8.4% from 2Q 2025). Net loss: ₹2.79m (down 119% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 05Camex Limited to Report Q2, 2026 Results on Nov 12, 2025Camex Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 12, 2025Reported Earnings • Aug 14First quarter 2026 earnings released: EPS: ₹0.85 (vs ₹0.60 in 1Q 2025)First quarter 2026 results: EPS: ₹0.85 (up from ₹0.60 in 1Q 2025). Revenue: ₹344.6m (up 1.8% from 1Q 2025). Net income: ₹8.99m (up 48% from 1Q 2025). Profit margin: 2.6% (up from 1.8% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 14% per year.Reported Earnings • Jul 12Full year 2025 earnings released: EPS: ₹1.86 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹1.86 (down from ₹3.39 in FY 2024). Revenue: ₹1.34b (down 5.8% from FY 2024). Net income: ₹18.9m (down 45% from FY 2024). Profit margin: 1.4% (down from 2.4% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 15% per year.お知らせ • Jul 08Camex Limited, Annual General Meeting, Aug 05, 2025Camex Limited, Annual General Meeting, Aug 05, 2025, at 12:30 Indian Standard Time.Reported Earnings • May 16Full year 2025 earnings released: EPS: ₹1.83 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹1.83 (down from ₹3.39 in FY 2024). Revenue: ₹1.34b (down 5.2% from FY 2024). Net income: ₹18.7m (down 46% from FY 2024). Profit margin: 1.4% (down from 2.4% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year and the company’s share price has also increased by 12% per year.お知らせ • May 12Camex Limited to Report Q4, 2025 Results on May 15, 2025Camex Limited announced that they will report Q4, 2025 results on May 15, 2025Board Change • Apr 03Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Chairman & MD Chandraprakash Chopra is the most experienced director on the board, commencing their role in 1992. Additional Independent Non-Executive Director Uttam Bhandari was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Apr 02Camex Limited Announces Resignation of Arpit Shah as an Independent Director, Effective April 1, 2025Camex Limited announced that Mr. Arpit Shah has resigned as an independent director of the company due to his pre-occupation and other professional commitments and consequently he ceased to be a director of the company with effect from the close of business hours on April 1, 2025. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Directorship in Listed Companies: AVI POLYMERS LIMITED; Committee Position: AVI POLYMERS LIMITED; Audit Committee – Member; Nomination and Remuneration Committee – Member; CSR Committee – Member.New Risk • Feb 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹406.1m market cap, or US$4.67m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).Valuation Update With 7 Day Price Move • Feb 13Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to ₹39.78, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 20% over the past three years.Reported Earnings • Feb 06Third quarter 2025 earnings released: ₹0.31 loss per share (vs ₹1.14 profit in 3Q 2024)Third quarter 2025 results: ₹0.31 loss per share (down from ₹1.14 profit in 3Q 2024). Revenue: ₹282.1m (down 18% from 3Q 2024). Net loss: ₹3.19m (down 127% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 22Camex Limited to Report Q3, 2025 Results on Feb 03, 2025Camex Limited announced that they will report Q3, 2025 results on Feb 03, 2025Reported Earnings • Nov 01Second quarter 2025 earnings released: EPS: ₹1.43 (vs ₹0.97 in 2Q 2024)Second quarter 2025 results: EPS: ₹1.43 (up from ₹0.97 in 2Q 2024). Revenue: ₹343.9m (down 2.3% from 2Q 2024). Net income: ₹14.6m (up 47% from 2Q 2024). Profit margin: 4.2% (up from 2.8% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 24% per year and the company’s share price has also increased by 24% per year.お知らせ • Oct 19Camex Limited to Report Q2, 2025 Results on Oct 28, 2024Camex Limited announced that they will report Q2, 2025 results on Oct 28, 2024Reported Earnings • Aug 01Full year 2024 earnings released: EPS: ₹3.39 (vs ₹0.014 loss in FY 2023)Full year 2024 results: EPS: ₹3.39 (up from ₹0.014 loss in FY 2023). Revenue: ₹1.42b (down 3.4% from FY 2023). Net income: ₹34.6m (up ₹34.8m from FY 2023). Profit margin: 2.4% (up from 0% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 30Camex Limited, Annual General Meeting, Aug 21, 2024Camex Limited, Annual General Meeting, Aug 21, 2024, at 14:00 Indian Standard Time.お知らせ • Jul 27Camex Limited to Report Q1, 2025 Results on Aug 06, 2024Camex Limited announced that they will report Q1, 2025 results on Aug 06, 2024Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹66.10, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 120% over the past three years.Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹49.15, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 36% over the past three years.お知らせ • May 11Camex Limited to Report Q4, 2024 Results on May 17, 2024Camex Limited announced that they will report Q4, 2024 results on May 17, 2024New Risk • Feb 05New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₹418.9m market cap, or US$5.05m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end).お知らせ • Jan 31Camex Limited to Report Q3, 2024 Results on Feb 07, 2024Camex Limited announced that they will report Q3, 2024 results on Feb 07, 2024New Risk • Dec 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₹358.0m market cap, or US$4.29m). Minor Risk Share price has been volatile over the past 3 months (7.2% average weekly change).お知らせ • Oct 14Camex Limited to Report Q2, 2024 Results on Oct 20, 2023Camex Limited announced that they will report Q2, 2024 results on Oct 20, 2023お知らせ • Jul 29Camex Limited to Report Q1, 2024 Results on Aug 08, 2023Camex Limited announced that they will report Q1, 2024 results on Aug 08, 2023Reported Earnings • Jul 26Full year 2023 earnings released: ₹0.014 loss per share (vs ₹3.08 profit in FY 2022)Full year 2023 results: ₹0.014 loss per share (down from ₹3.08 profit in FY 2022). Revenue: ₹1.47b (down 18% from FY 2022). Net loss: ₹142.0k (down 100% from profit in FY 2022). Profit margin: 0% (down from 1.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 12Camex Limited, Annual General Meeting, Aug 18, 2023Camex Limited, Annual General Meeting, Aug 18, 2023.Reported Earnings • May 31Full year 2023 earnings released: ₹0.30 loss per share (vs ₹3.08 profit in FY 2022)Full year 2023 results: ₹0.30 loss per share (down from ₹3.08 profit in FY 2022). Revenue: ₹1.48b (down 17% from FY 2022). Net loss: ₹142.0k (down 100% from profit in FY 2022). Profit margin: 0% (down from 1.8% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.お知らせ • May 23Camex Limited to Report Q4, 2023 Results on May 29, 2023Camex Limited announced that they will report Q4, 2023 results on May 29, 2023Reported Earnings • Feb 02Third quarter 2023 earnings released: ₹0.52 loss per share (vs ₹1.35 profit in 3Q 2022)Third quarter 2023 results: ₹0.52 loss per share (down from ₹1.35 profit in 3Q 2022). Revenue: ₹306.3m (down 42% from 3Q 2022). Net loss: ₹4.86m (down 135% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 26Camex Limited to Report Q3, 2023 Results on Feb 01, 2023Camex Limited announced that they will report Q3, 2023 results on Feb 01, 2023お知らせ • Nov 24Camex Limited Announces Executive ChangesCamex Limited announced that Mr. Vishal Vadhvana, an Associate Member of the Institute of company Secretaries of India, be and is hereby appointed, as the Company Secretary of the Company with effect from November 14, 2022, to perform the duties of a Company Secretary as required under the companies act, 2013 and any other duties assigned by the Board of Directors from time to time subject to Review as may be decided by the Board of Directors from time to time. Mr. Vishal Chandrakant Vadhvana, an Associate Member of the Institute of Company Secretaries of India, be and is hereby appointed the compliance officer of the company as per regulation 6 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.お知らせ • Nov 15Camex Limited Appoints Vishal Vadhvana as Company Secretary and Compliance OfficerCamex Limited at its board meeting to be held on November 14,2022, approved the appointment of Mr. Vishal Vadhvana as a Company Secretary and Compliance officer of the Company effective November 14, 2022.Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹33.20, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years.Recent Insider Transactions • Sep 12Insider recently sold ₹283k worth of stockOn the 9th of September, Devendra Chopra sold around 10k shares on-market at roughly ₹29.69 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹11m more than they bought in the last 12 months.お知らせ • Sep 08Camex Limited Announces Resignation of Kruti Shah as Company Secretary and Compliance 0FficerCamex Limited announced that Ms. Kruti Shah has tendered her resignation from the post of Company Secretary and Compliance 0fficer of the Company with immediate effect from September 7, 2022.お知らせ • Aug 28Camex Approves Appointment of Rahul Chopra as Non-Executive DirectorCamex Limited at the AGM held on August 27, 2022 approved appointment of Mr. Rahul Chopra (DIN: 02724914) as a Non-executive Director of the Company.Reported Earnings • Aug 15First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.53 loss in 1Q 2022)First quarter 2023 results: EPS: ₹0.04 (up from ₹0.53 loss in 1Q 2022). Revenue: ₹449.1m (up 21% from 1Q 2022). Net income: ₹420.0k (up ₹5.79m from 1Q 2022). Profit margin: 0.1% (up from net loss in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 5% per year.お知らせ • Aug 03Camex Limited to Report Q1, 2023 Results on Aug 09, 2022Camex Limited announced that they will report Q1, 2023 results on Aug 09, 2022お知らせ • Aug 02Camex Limited, Annual General Meeting, Aug 27, 2022Camex Limited, Annual General Meeting, Aug 27, 2022, at 13:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹29.40, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 17x in the Chemicals industry in India. Negligible returns to shareholders over past three years.お知らせ • May 24Camex Limited to Report Q4, 2022 Results on May 30, 2022Camex Limited announced that they will report Q4, 2022 results on May 30, 2022Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Non-Executive Independent Director Arpit Shah was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹29.95, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 1.3% over the past three years.Recent Insider Transactions • Mar 21Insider recently sold ₹507k worth of stockOn the 17th of March, Devendra Chopra sold around 18k shares on-market at roughly ₹27.85 per share. In the last 3 months, they made an even bigger sale worth ₹5.1m. Insiders have been net sellers, collectively disposing of ₹10m more than they bought in the last 12 months.Recent Insider Transactions • Mar 15Insider recently sold ₹481k worth of stockOn the 11th of March, Devendra Chopra sold around 16k shares on-market at roughly ₹29.49 per share. In the last 3 months, they made an even bigger sale worth ₹5.1m. Insiders have been net sellers, collectively disposing of ₹10m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₹31.55, the stock trades at a trailing P/E ratio of 20.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years.Recent Insider Transactions • Feb 06Insider recently sold ₹4.7m worth of stockOn the 3rd of February, Devendra Chopra sold around 138k shares on-market at roughly ₹34.45 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Reported Earnings • Feb 05Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.35 (up from ₹0.92 in 3Q 2021). Revenue: ₹533.4m (up 11% from 3Q 2021). Net income: ₹13.8m (up 46% from 3Q 2021). Profit margin: 2.6% (up from 2.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹33.85, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 12% over the past three years.Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹0.25 (vs ₹0.18 in 2Q 2021)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2022 results: Revenue: ₹340.9m (down 7.1% from 2Q 2021). Net income: ₹2.59m (up 43% from 2Q 2021). Profit margin: 0.8% (up from 0.5% in 2Q 2021). The increase in margin was driven by lower expenses.Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹32.10, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 2.7% over the past three years.Board Change • Sep 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Non-Executive Independent Director Arpit Shah was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹22.70, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years.Reported Earnings • Jul 25First quarter 2022 earnings released: ₹0.53 loss per share (vs ₹0.22 loss in 1Q 2021)The company reported a solid first quarter result with improved revenues and control over costs, although losses increased. First quarter 2022 results: Revenue: ₹371.3m (up 163% from 1Q 2021). Net loss: ₹5.37m (loss widened 140% from 1Q 2021).Reported Earnings • Jun 07Full year 2021 earnings released: EPS ₹1.37 (vs ₹1.23 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹1.51b (up 14% from FY 2020). Net income: ₹13.6m (up 8.4% from FY 2020). Profit margin: 0.9% (down from 1.0% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 12Investor sentiment improved over the past weekAfter last week's 31% share price gain to ₹30.25, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 4.7% over the past three years.Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improved over the past weekAfter last week's 47% share price gain to ₹26.40, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years.Is New 90 Day High Low • Mar 14New 90-day high: ₹21.00The company is up 4.0% from its price of ₹20.15 on 14 December 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.Reported Earnings • Feb 04Third quarter 2021 earnings released: EPS ₹0.92 (vs ₹0.08 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹482.9m (up 63% from 3Q 2020). Net income: ₹9.42m (up ₹8.57m from 3Q 2020). Profit margin: 2.0% (up from 0.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.お知らせ • Jan 26Camex Limited to Report Q3, 2021 Results on Feb 02, 2021Camex Limited announced that they will report Q3, 2021 results on Feb 02, 2021お知らせ • Dec 18Camex Limited Announces Demise of Mahaveer Chopra, Whole-Time DirectorCamex Limited announced sudden and sad demise of Mr. Mahaveer Chopra, Whole-time Director of the Company on December 15, 2020.Is New 90 Day High Low • Dec 03New 90-day high: ₹18.40The company is up 20% from its price of ₹15.35 on 04 September 2020. The Indian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Nov 08Second quarter 2021 earnings released: EPS ₹0.18The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹367.4m (up 16% from 2Q 2020). Net income: ₹1.81m (up 86% from 2Q 2020). Profit margin: 0.5% (up from 0.3% in 2Q 2020). The increase in margin was driven by higher revenue.お知らせ • Aug 22Camex Limited to Report Q1, 2020 Results on Aug 29, 2020Camex Limited announced that they will report Q1, 2020 results on Aug 29, 2020お知らせ • Jul 23Camex Limited to Report Q4, 2020 Results on Jul 30, 2020Camex Limited announced that they will report Q4, 2020 results on Jul 30, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Camex は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:524440 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20261,49932-82-29N/A12/31/20251,45416N/AN/AN/A9/30/20251,37048493N/A6/30/20251,34222N/AN/AN/A3/31/20251,33719463N/A12/31/20241,34533N/AN/AN/A9/30/20241,40748-153-98N/A6/30/20241,41543N/AN/AN/A3/31/20241,418354748N/A12/31/20231,59019N/AN/AN/A9/30/20231,40011N/AN/AN/A6/30/20231,363-3N/AN/AN/A3/31/20231,4680N/AN/AN/A12/31/20221,61615N/AN/AN/A9/30/20221,84431-57-47N/A6/30/20221,86937N/AN/AN/A3/31/20221,79231618N/A12/31/20211,75316N/AN/AN/A9/30/20211,70411-15-12N/A6/30/20211,73110N/AN/AN/A3/31/20211,50214-146-143N/A12/31/20201,33510N/AN/AN/A9/30/20201,14913638N/A6/30/20201,1000N/AN/AN/A3/31/20201,31913112114N/A12/31/20191,36520N/AN/AN/A9/30/20191,50231N/A139N/A6/30/20191,52037N/AN/AN/A3/31/20191,47237N/A196N/A3/31/20181,28923N/A-54N/A3/31/20171,12119N/A-24N/A3/31/20161,13412N/A84N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 524440の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 524440の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 524440の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 524440の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 524440の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 524440の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 19:33終値2026/05/21 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Camex Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Anil BurraFirstCall Research
New Risk • May 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 10.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (25% accrual ratio). Market cap is less than US$10m (₹433.7m market cap, or US$4.53m). Minor Risk Share price has been volatile over the past 3 months (10.0% average weekly change).
Reported Earnings • May 14Full year 2026 earnings released: EPS: ₹3.21 (vs ₹1.86 in FY 2025)Full year 2026 results: EPS: ₹3.21 (up from ₹1.86 in FY 2025). Revenue: ₹1.50b (up 12% from FY 2025). Net income: ₹32.5m (up 72% from FY 2025). Profit margin: 2.2% (up from 1.4% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 21% per year.
Valuation Update With 7 Day Price Move • May 13Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹35.40, the stock trades at a trailing P/E ratio of 22.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 42% over the past three years.
お知らせ • May 07Camex Limited to Report Q4, 2026 Results on May 12, 2026Camex Limited announced that they will report Q4, 2026 results on May 12, 2026
Reported Earnings • Feb 06Third quarter 2026 earnings released: EPS: ₹0.80 (vs ₹0.31 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹0.80 (up from ₹0.31 loss in 3Q 2025). Revenue: ₹366.9m (up 30% from 3Q 2025). Net income: ₹8.18m (up ₹11.4m from 3Q 2025). Profit margin: 2.2% (up from net loss in 3Q 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 02Camex Limited to Report Q3, 2026 Results on Feb 05, 2026Camex Limited announced that they will report Q3, 2026 results on Feb 05, 2026
Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹0.27 loss per share (vs ₹1.43 profit in 2Q 2025)Second quarter 2026 results: ₹0.27 loss per share (down from ₹1.43 profit in 2Q 2025). Revenue: ₹373.0m (up 8.4% from 2Q 2025). Net loss: ₹2.79m (down 119% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 05Camex Limited to Report Q2, 2026 Results on Nov 12, 2025Camex Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 12, 2025
Reported Earnings • Aug 14First quarter 2026 earnings released: EPS: ₹0.85 (vs ₹0.60 in 1Q 2025)First quarter 2026 results: EPS: ₹0.85 (up from ₹0.60 in 1Q 2025). Revenue: ₹344.6m (up 1.8% from 1Q 2025). Net income: ₹8.99m (up 48% from 1Q 2025). Profit margin: 2.6% (up from 1.8% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 14% per year.
Reported Earnings • Jul 12Full year 2025 earnings released: EPS: ₹1.86 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹1.86 (down from ₹3.39 in FY 2024). Revenue: ₹1.34b (down 5.8% from FY 2024). Net income: ₹18.9m (down 45% from FY 2024). Profit margin: 1.4% (down from 2.4% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 15% per year.
お知らせ • Jul 08Camex Limited, Annual General Meeting, Aug 05, 2025Camex Limited, Annual General Meeting, Aug 05, 2025, at 12:30 Indian Standard Time.
Reported Earnings • May 16Full year 2025 earnings released: EPS: ₹1.83 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹1.83 (down from ₹3.39 in FY 2024). Revenue: ₹1.34b (down 5.2% from FY 2024). Net income: ₹18.7m (down 46% from FY 2024). Profit margin: 1.4% (down from 2.4% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 12% per year and the company’s share price has also increased by 12% per year.
お知らせ • May 12Camex Limited to Report Q4, 2025 Results on May 15, 2025Camex Limited announced that they will report Q4, 2025 results on May 15, 2025
Board Change • Apr 03Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Chairman & MD Chandraprakash Chopra is the most experienced director on the board, commencing their role in 1992. Additional Independent Non-Executive Director Uttam Bhandari was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Apr 02Camex Limited Announces Resignation of Arpit Shah as an Independent Director, Effective April 1, 2025Camex Limited announced that Mr. Arpit Shah has resigned as an independent director of the company due to his pre-occupation and other professional commitments and consequently he ceased to be a director of the company with effect from the close of business hours on April 1, 2025. Names of listed entities in which the resigning director holds directorships, indicating the category of directorship and membership of board committees, if any: Directorship in Listed Companies: AVI POLYMERS LIMITED; Committee Position: AVI POLYMERS LIMITED; Audit Committee – Member; Nomination and Remuneration Committee – Member; CSR Committee – Member.
New Risk • Feb 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹406.1m market cap, or US$4.67m). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change).
Valuation Update With 7 Day Price Move • Feb 13Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to ₹39.78, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 20% over the past three years.
Reported Earnings • Feb 06Third quarter 2025 earnings released: ₹0.31 loss per share (vs ₹1.14 profit in 3Q 2024)Third quarter 2025 results: ₹0.31 loss per share (down from ₹1.14 profit in 3Q 2024). Revenue: ₹282.1m (down 18% from 3Q 2024). Net loss: ₹3.19m (down 127% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 22Camex Limited to Report Q3, 2025 Results on Feb 03, 2025Camex Limited announced that they will report Q3, 2025 results on Feb 03, 2025
Reported Earnings • Nov 01Second quarter 2025 earnings released: EPS: ₹1.43 (vs ₹0.97 in 2Q 2024)Second quarter 2025 results: EPS: ₹1.43 (up from ₹0.97 in 2Q 2024). Revenue: ₹343.9m (down 2.3% from 2Q 2024). Net income: ₹14.6m (up 47% from 2Q 2024). Profit margin: 4.2% (up from 2.8% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 24% per year and the company’s share price has also increased by 24% per year.
お知らせ • Oct 19Camex Limited to Report Q2, 2025 Results on Oct 28, 2024Camex Limited announced that they will report Q2, 2025 results on Oct 28, 2024
Reported Earnings • Aug 01Full year 2024 earnings released: EPS: ₹3.39 (vs ₹0.014 loss in FY 2023)Full year 2024 results: EPS: ₹3.39 (up from ₹0.014 loss in FY 2023). Revenue: ₹1.42b (down 3.4% from FY 2023). Net income: ₹34.6m (up ₹34.8m from FY 2023). Profit margin: 2.4% (up from 0% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 30Camex Limited, Annual General Meeting, Aug 21, 2024Camex Limited, Annual General Meeting, Aug 21, 2024, at 14:00 Indian Standard Time.
お知らせ • Jul 27Camex Limited to Report Q1, 2025 Results on Aug 06, 2024Camex Limited announced that they will report Q1, 2025 results on Aug 06, 2024
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₹66.10, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 120% over the past three years.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹49.15, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 36% over the past three years.
お知らせ • May 11Camex Limited to Report Q4, 2024 Results on May 17, 2024Camex Limited announced that they will report Q4, 2024 results on May 17, 2024
New Risk • Feb 05New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₹418.9m market cap, or US$5.05m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end).
お知らせ • Jan 31Camex Limited to Report Q3, 2024 Results on Feb 07, 2024Camex Limited announced that they will report Q3, 2024 results on Feb 07, 2024
New Risk • Dec 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₹358.0m market cap, or US$4.29m). Minor Risk Share price has been volatile over the past 3 months (7.2% average weekly change).
お知らせ • Oct 14Camex Limited to Report Q2, 2024 Results on Oct 20, 2023Camex Limited announced that they will report Q2, 2024 results on Oct 20, 2023
お知らせ • Jul 29Camex Limited to Report Q1, 2024 Results on Aug 08, 2023Camex Limited announced that they will report Q1, 2024 results on Aug 08, 2023
Reported Earnings • Jul 26Full year 2023 earnings released: ₹0.014 loss per share (vs ₹3.08 profit in FY 2022)Full year 2023 results: ₹0.014 loss per share (down from ₹3.08 profit in FY 2022). Revenue: ₹1.47b (down 18% from FY 2022). Net loss: ₹142.0k (down 100% from profit in FY 2022). Profit margin: 0% (down from 1.8% in FY 2022). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 12Camex Limited, Annual General Meeting, Aug 18, 2023Camex Limited, Annual General Meeting, Aug 18, 2023.
Reported Earnings • May 31Full year 2023 earnings released: ₹0.30 loss per share (vs ₹3.08 profit in FY 2022)Full year 2023 results: ₹0.30 loss per share (down from ₹3.08 profit in FY 2022). Revenue: ₹1.48b (down 17% from FY 2022). Net loss: ₹142.0k (down 100% from profit in FY 2022). Profit margin: 0% (down from 1.8% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
お知らせ • May 23Camex Limited to Report Q4, 2023 Results on May 29, 2023Camex Limited announced that they will report Q4, 2023 results on May 29, 2023
Reported Earnings • Feb 02Third quarter 2023 earnings released: ₹0.52 loss per share (vs ₹1.35 profit in 3Q 2022)Third quarter 2023 results: ₹0.52 loss per share (down from ₹1.35 profit in 3Q 2022). Revenue: ₹306.3m (down 42% from 3Q 2022). Net loss: ₹4.86m (down 135% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 26Camex Limited to Report Q3, 2023 Results on Feb 01, 2023Camex Limited announced that they will report Q3, 2023 results on Feb 01, 2023
お知らせ • Nov 24Camex Limited Announces Executive ChangesCamex Limited announced that Mr. Vishal Vadhvana, an Associate Member of the Institute of company Secretaries of India, be and is hereby appointed, as the Company Secretary of the Company with effect from November 14, 2022, to perform the duties of a Company Secretary as required under the companies act, 2013 and any other duties assigned by the Board of Directors from time to time subject to Review as may be decided by the Board of Directors from time to time. Mr. Vishal Chandrakant Vadhvana, an Associate Member of the Institute of Company Secretaries of India, be and is hereby appointed the compliance officer of the company as per regulation 6 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.
お知らせ • Nov 15Camex Limited Appoints Vishal Vadhvana as Company Secretary and Compliance OfficerCamex Limited at its board meeting to be held on November 14,2022, approved the appointment of Mr. Vishal Vadhvana as a Company Secretary and Compliance officer of the Company effective November 14, 2022.
Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹33.20, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 50% over the past three years.
Recent Insider Transactions • Sep 12Insider recently sold ₹283k worth of stockOn the 9th of September, Devendra Chopra sold around 10k shares on-market at roughly ₹29.69 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹11m more than they bought in the last 12 months.
お知らせ • Sep 08Camex Limited Announces Resignation of Kruti Shah as Company Secretary and Compliance 0FficerCamex Limited announced that Ms. Kruti Shah has tendered her resignation from the post of Company Secretary and Compliance 0fficer of the Company with immediate effect from September 7, 2022.
お知らせ • Aug 28Camex Approves Appointment of Rahul Chopra as Non-Executive DirectorCamex Limited at the AGM held on August 27, 2022 approved appointment of Mr. Rahul Chopra (DIN: 02724914) as a Non-executive Director of the Company.
Reported Earnings • Aug 15First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.53 loss in 1Q 2022)First quarter 2023 results: EPS: ₹0.04 (up from ₹0.53 loss in 1Q 2022). Revenue: ₹449.1m (up 21% from 1Q 2022). Net income: ₹420.0k (up ₹5.79m from 1Q 2022). Profit margin: 0.1% (up from net loss in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 5% per year.
お知らせ • Aug 03Camex Limited to Report Q1, 2023 Results on Aug 09, 2022Camex Limited announced that they will report Q1, 2023 results on Aug 09, 2022
お知らせ • Aug 02Camex Limited, Annual General Meeting, Aug 27, 2022Camex Limited, Annual General Meeting, Aug 27, 2022, at 13:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jun 03Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹29.40, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 17x in the Chemicals industry in India. Negligible returns to shareholders over past three years.
お知らせ • May 24Camex Limited to Report Q4, 2022 Results on May 30, 2022Camex Limited announced that they will report Q4, 2022 results on May 30, 2022
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Non-Executive Independent Director Arpit Shah was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹29.95, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 1.3% over the past three years.
Recent Insider Transactions • Mar 21Insider recently sold ₹507k worth of stockOn the 17th of March, Devendra Chopra sold around 18k shares on-market at roughly ₹27.85 per share. In the last 3 months, they made an even bigger sale worth ₹5.1m. Insiders have been net sellers, collectively disposing of ₹10m more than they bought in the last 12 months.
Recent Insider Transactions • Mar 15Insider recently sold ₹481k worth of stockOn the 11th of March, Devendra Chopra sold around 16k shares on-market at roughly ₹29.49 per share. In the last 3 months, they made an even bigger sale worth ₹5.1m. Insiders have been net sellers, collectively disposing of ₹10m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₹31.55, the stock trades at a trailing P/E ratio of 20.7x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years.
Recent Insider Transactions • Feb 06Insider recently sold ₹4.7m worth of stockOn the 3rd of February, Devendra Chopra sold around 138k shares on-market at roughly ₹34.45 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Reported Earnings • Feb 05Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.35 (up from ₹0.92 in 3Q 2021). Revenue: ₹533.4m (up 11% from 3Q 2021). Net income: ₹13.8m (up 46% from 3Q 2021). Profit margin: 2.6% (up from 2.0% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₹33.85, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 12% over the past three years.
Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹0.25 (vs ₹0.18 in 2Q 2021)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2022 results: Revenue: ₹340.9m (down 7.1% from 2Q 2021). Net income: ₹2.59m (up 43% from 2Q 2021). Profit margin: 0.8% (up from 0.5% in 2Q 2021). The increase in margin was driven by lower expenses.
Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹32.10, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 2.7% over the past three years.
Board Change • Sep 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. Non-Executive Independent Director Arpit Shah was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₹22.70, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total loss to shareholders of 41% over the past three years.
Reported Earnings • Jul 25First quarter 2022 earnings released: ₹0.53 loss per share (vs ₹0.22 loss in 1Q 2021)The company reported a solid first quarter result with improved revenues and control over costs, although losses increased. First quarter 2022 results: Revenue: ₹371.3m (up 163% from 1Q 2021). Net loss: ₹5.37m (loss widened 140% from 1Q 2021).
Reported Earnings • Jun 07Full year 2021 earnings released: EPS ₹1.37 (vs ₹1.23 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹1.51b (up 14% from FY 2020). Net income: ₹13.6m (up 8.4% from FY 2020). Profit margin: 0.9% (down from 1.0% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 12Investor sentiment improved over the past weekAfter last week's 31% share price gain to ₹30.25, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 4.7% over the past three years.
Valuation Update With 7 Day Price Move • Apr 24Investor sentiment improved over the past weekAfter last week's 47% share price gain to ₹26.40, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total loss to shareholders of 22% over the past three years.
Is New 90 Day High Low • Mar 14New 90-day high: ₹21.00The company is up 4.0% from its price of ₹20.15 on 14 December 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.
Reported Earnings • Feb 04Third quarter 2021 earnings released: EPS ₹0.92 (vs ₹0.08 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹482.9m (up 63% from 3Q 2020). Net income: ₹9.42m (up ₹8.57m from 3Q 2020). Profit margin: 2.0% (up from 0.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 26Camex Limited to Report Q3, 2021 Results on Feb 02, 2021Camex Limited announced that they will report Q3, 2021 results on Feb 02, 2021
お知らせ • Dec 18Camex Limited Announces Demise of Mahaveer Chopra, Whole-Time DirectorCamex Limited announced sudden and sad demise of Mr. Mahaveer Chopra, Whole-time Director of the Company on December 15, 2020.
Is New 90 Day High Low • Dec 03New 90-day high: ₹18.40The company is up 20% from its price of ₹15.35 on 04 September 2020. The Indian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Nov 08Second quarter 2021 earnings released: EPS ₹0.18The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹367.4m (up 16% from 2Q 2020). Net income: ₹1.81m (up 86% from 2Q 2020). Profit margin: 0.5% (up from 0.3% in 2Q 2020). The increase in margin was driven by higher revenue.
お知らせ • Aug 22Camex Limited to Report Q1, 2020 Results on Aug 29, 2020Camex Limited announced that they will report Q1, 2020 results on Aug 29, 2020
お知らせ • Jul 23Camex Limited to Report Q4, 2020 Results on Jul 30, 2020Camex Limited announced that they will report Q4, 2020 results on Jul 30, 2020